Aquired Immune Deficiency Syndrome

"'Brazilian AIDS drugs a sure path to economic sickness

The United States correctly argued that Brazil must no longer manufacture proprietary AIDS drugs in violation of U.S. drug company patents, even if this will mean removing 100,000 Brazilians from treatment rosters. The U.S., calling patent enforcement a form of "tough love," insisted that the number of lives lost to AIDS in the short term will be dwarfed by the number saved in the long term through a more efficient medical products market.
Read the special bulletin, the report and related studies.
'"
